SCHEMBL19506952

SCHEMBL19506952

CC(=O)OCOC(=O)C1CCN(C(=O)C(C#N)=Cc2cc3cc4c5c(c3oc2=O)CCCN5CCC4)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC16A3 O15427 1/20 0.45
▸ USP2 O75604 6/20 0.38
▸ CASP1 P29466 4/20 0.38
▸ CASP7 P55210 4/20 0.38
▸ ALOX15 P16050 3/20 0.38
▸ MEN1 O00255 7/20 0.36
▸ KMT2A Q03164 7/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ MAPT P10636 5/20 0.36
▸ GAA P10253 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ RECQL P46063 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ RAB9A P51151 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ BRCA1 P38398 2/20 0.35
▸ HBB P68871 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19519721 0.84 SLC16A3 (0.49) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL23620265 0.79 SLC16A3 (0.38) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL26936294 0.76 SLC16A3 (0.55) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL29906670 0.76 SLC16A3 (0.55) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL19506949 0.75 SLC16A3 (0.52) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL19506950 0.75 SLC16A3 (0.47) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL23620169 0.72 SLC16A3 (0.32) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL19519724 0.72 SLC16A3 (0.41) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL22666149 0.71 SLC16A3 (0.43) SLC16A3USP2CASP1CASP7ALOX15
SCHEMBL19519725 0.70 SLC16A3 (0.40) SLC16A3USP2CASP1CASP7ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11841369-B2 Method for improving quality of therapeutic cell through real-time glutathione measurement CELL2IN, INC. (KR) 2023-12-12 — — US disclosed
US-20170307624-A1 REAL-TIME IMAGING SENSOR FOR MEASURING CELLULAR THIOL LEVEL CELL2IN, INC. (KR) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170307624-A1 REAL-TIME IMAGING SENSOR FOR MEASURING CELLULAR THIOL LEVEL TST, SHMT2, SHMT1 SLC16A3 370/4885USP2 1433/4885CASP1 1641/4885
US-11841369-B2 Method for improving quality of therapeutic cell through real-time glutathione measurement GSR, GPX1, GGT1 SLC16A3 2211/4885USP2 1067/4885CASP1 2128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback